medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Number 1

<< Back Next >>

Ann Hepatol 2005; 4 (1)

Histological spectrum of liver in HIV – Autopsy study

Amarapurka AD

Language: English
References: 24
Page: 47-51
PDF size: 44.21 Kb.


Text Extraction

Introduction: Liver abnormalities are common in HIV positive patients. They are usually part of generalized process and rarely produce significant liver failure. Aim: To evaluate histological spectrum of liver disease in HIV positive patients and to ascertain if any pathologic features are widespread among HIV infection. Material & methods: Autopsy data from year 1991 to 2003 consisting of 60 HIV positive patients were evaluated. Demographic profile, clinical and laboratory data were obtained from hospital records. Macroscopic findings of all organs at autopsy were noted. Histological features of liver were studied in detail using routine H & E., Ziehl-Neelson stain for acid fast bacilli and other special stains such as PAS and GMS for fungal infection were done whenever indicated. Results: Patients were in age group 19 to 55 years with mean age of 32.1 year; male to female ratio was 4:1. Evidence of tuberculosis either pulmonary or extrapulmonary was found in 35 (58.3%) cases. On histological examination of liver, tubercular granulomas were seen in 19 (31.6%) cases of disseminated tuberculosis. Granulomas were typical caseating epitheloid cell type in 14 (73.6%) and in 5 cases granulomas were not typical. Acid fast bacilli were demonstrated in 4 (6.6%) cases, all of which showed presence of granulomas. Other histological findings were sinusoidal and centrivenular congestion in 14 (23.3%), extensive fatty change 6 (10%), portal inflammation resembling chronic hepatitis 5 (8.3%), focal necrosis 2 (3.3%), Kupffer cell hyperplasia 1 (1.6%) and metastasis from known case of adenocarcinoma of pancreas 1 (1.6%). Associated hepatitis C and B infections were seen in 4 (6.6%) and 1 (1.6%) respectively. Opportunistic infection was seen in only 1 (1.6%) case with disseminated cryptococcosis involving liver. In remaining 6 (10%) liver histology was normal. Considering cause of death, 58.3% patients died due to disseminated tuberculosis. Patients with associated hepatitis B & C infection died due to liver cirrhosis and the remaining died of miscellaneous conditions, which were not related to HIV infection. Conclusion: Histopathological findings of the liver in HIV positive patients were mainly non specific. Tuberculosis was the commonest infection noted. There was no significant mortality observed specifically related to liver involvement in these patients.


REFERENCES

  1. Sax PE. Opportunistic infections in HIV disease: down but not out. Infect Dis Clin North Am 2001; 15: 433-455.

  2. Ioannidis J, Wilkinson D. HIV: opportunistic infections. Clin Evid 2003; 9: 795-816.

  3. Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chene G, Morlat P. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-324.

  4. Schneiderman DJ, Arenson DM, Cello JP, Margaretten W, Weber TE. Hepatic Disease in patients with the Acquired immune Deficiency syndrome (AIDS). Hepatology 1987; 7: 925-930.

  5. Glasgow BJ, Anders K, Layfield L, Steinsapir K, Gitnick G, Levin K. Clinical and Pathological Findings of the Liver of the Acquired Immunodeficiency syndrome (AIDS). Am J Clin Pathol 1985; 83: 582-588.

  6. Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC. Veterans Aging Cohort 3-Site Study. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003; 33: 521-525.

  7. Lucidarme D, Bruandet A, Ilef D, Harbonnier J, Jacob C, Decoster A, Delamare C, Cyran C, Van Hoenacker AF, Fremaux D, Josse P, Emmanuelli J, Le Strat Y, Desenclos JC, Filoche B. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect 2004; 132: 699-708.

  8. Sabin CA, Walker AS, Dunn D. HIV/HCV coinfection, HAART, and liver-related mortality. Lancet 2004; 364: 757-758.

  9. Lebovics E, Thung S, Schaffner F, Radinsky P. The Liver in the Acquired Immunodeficiency Syndrome: A clinical and Histologic study. Hepatology 1985; 5: 293-298.

  10. Wilkins AJ, Lindley R, Dourkais SP, Goldin RD. Surgical pathology of the liver in HIV infection. Histopathology 1991; 18: 459-464.

  11. Cappell MS, Schwartz MS, Viempica L. Clinical utility of liver biopsy in patients with serum antibodies to the Human Immunodeficiency Virus. Am J Med 1990; 88: 123-130.

  12. Guarda LA, Luna MA, Smith JL, Mansell PW, Gyorkey F, Roca AN, Acquired Immune Deficiency syndrome: Postmortem findings. Am J Clin Path 1984; 81: 49-57.

  13. Hira SK, Dupont HL, Lanjewar DN, Dholakia YN. Severe weight loss in the predominant clinical presentation of tuberculosis in patients with HIV infection in India. Natl Med J India 1998; 11: 256-258.

  14. Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infection in HIV-infected Indian patients. AIDS Patient Care STDS 2004; 18: 209-213.

  15. Kaur A, Babu PG Jacob M, Narasimhan C, Ganesh A, Saraswathi NK, et al. Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr 1992; 5: 883-889.

  16. Dworkin BM, StahL RE, Giardina MA, Worsner GP, Weiss L, Jankwski R, Rosenthal WS. The liver in Acquired Immune Deficiency syndrome: Emphasis on patients with intravenous drug Abuse. Am J Gastroenterol 1987; 82: 231-236.

  17. Lanjewar DN, Rao RJ, Kulkarni SB, Hira SK. Hepatic pathology in AIDS: a pathological study from Mumbai, India. HIV Med 2004; 5: 253-257.

  18. Tang YW, Meng S, Li H, Stratton CW, Koyamatsu T, Zheng X. PCR Enhances acid-fast bacillus stain-based rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 2004; 42: 1849-1850.

  19. Comer GM, Mukherjee S, Scholes JV, Holness LG, Clain DJ. Liver biopsies in the acquired immune deficiency syndrome: Influence of endemic disease and drug abuse. Am J Gastroenterol 1989; 84: 1525-1531.

  20. Goldin RD, Fish DE, Hay A, Waters JA, McGarvey MJ, Main J, Thomas HC. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol 1990; 43: 203-205.

  21. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004; 32: 33-46.

  22. Sherman KE. HCV and HIV: a tale of two viruses. Rev Gastroenterol Disord 2004; 4 Suppl 1: S48-S54.

  23. Rullier A, Trimoulet P, Neau D, Bernard PH, Foucher J, Lacoste D, Winnock M, Urbaniak R, Ballardini G, Balabaud C, Bioulac-Sage P, Le Bail B. Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients. Hum Pathol 2004; 35(9): 1088-1094.

  24. Chalasani N, wilcox CM. Etiology, evaluation and outcome of jaundice in patients with Acquired Immunodeficiency syndrome. Hepatology 1996; 23: 728-733.




2020     |     www.medigraphic.com